Почетна › Прекумерна телесна тежина › Вирџинија
Клинички испитувања за Прекумерна телесна тежина во Вирџинија
33 студии за Прекумерна телесна тежина бараат учесници на локации во Вирџинија.
Градови во Вирџинија
- Arlington11 студии
- Richmond9 студии
- Newport News5 студии
- Charlottesville5 студии
- Norfolk4 студии
- Winchester3 студии
- Alexandria3 студии
Официјален текст на студијата (англиски)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Washington Center for Weight Management and Research, Inc, Arlington
- Health Research of Hampton Roads, Newport News
- Selma Medical Associates, Winchester
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 5.10.2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Manassas Clinical Research Center Inc, Burke
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 5.10.2026 · NCT07684144Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Inova Cardiology - Fairfax, Fairfax
- Virginia Heart, Falls Church
Се регрутираФаза 3
Возраст од 45 до 99 · Сите полови · Ажурирано 5.10.2026 · NCT07037433Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Washington Center For Weight Management And Research /ID# 282047, Arlington
- Sovah Health - Danville /ID# 282876, Danville
- Health Research Of Hampton Roads /ID# 282014, Newport News
- и уште 1
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT07752979AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- National Clin Res Inc., Richmond
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07533175A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- York Clinical Research, LLC, Norfolk
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07595549A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Sovah Clinical Research-River District, Danville
- Clinical Research Partners, LLC, Richmond
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- National Clin Res Inc., Richmond
- Gastroent Consult of SW VA, Roanoke
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07668414AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Washington Cntr Weight Mgmt, Arlington
- Health Res of Hampton Roads, Newport News
- National Clin Res Inc., Richmond
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07720271A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Manassas
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond
Се регрутираФаза 3
Возраст од 6 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Consultants of Southwest Virginia, Roanoke
Се регрутираФаза 3
Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937086Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Charlottesville Medical Research, Charlottesville
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07353931A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Sovah Clinical Research-River District, Danville
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 22.9.2026 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- AMR Clinical, Norfolk
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07321886A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Manassas
- Research Site, Norfolk
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Hampton
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Hampton
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743463A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Manassas Clinical Research Center, Manassas
- Centricity Research Suffolk Primary Care, Suffolk
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351058A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Burke
- ACCOMPLISH-2 Research Site, Manassas
- ACCOMPLISH-2 Research Site, Suffolk
Се регрутираФаза 3Добредојдени се здрави волонтери
Возраст од 18 до 79 · Сите полови · Ажурирано 11.9.2026 · NCT07654374Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- Selma Medical Associates, Winchester
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07770841A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
- Clinical Research Partners, LLC, Richmond
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT07215559A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Sovah Clinical Research-River District, Danville
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT06143956A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- Health Res of Hampton Roads, Newport News
- National Clin Res Inc., Richmond
- Selma Medical Associates, Winchester
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07745504Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Manassas
- Kailera Clinical Site, Richmond
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Danville
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284875A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Arlington
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07784725AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Health Res of Hampton Roads, Newport News
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT07509307Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico
Се регрутираДобредојдени се здрави волонтери
Возраст 4 и постари · Сите полови · Ажурирано 10.6.2026 · NCT06714929Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
- University of Virginia, Charlottesville
Се регрутираДобредојдени се здрави волонтери
Возраст од 21 до 50 · Сите полови · Ажурирано 7.5.2026 · NCT07573228Examining Valence-based Effects in Self-Monitoring Feedback Messages
- University of Virginia, Charlottesville
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 31.3.2026 · NCT07292389Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- University of Virginia, Charlottesville
Се регрутираДобредојдени се здрави волонтери
Возраст од 30 до 55 · Сите полови · Ажурирано 23.3.2026 · NCT04791371Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status
- UVA Student Health and Wellness Building, Charlottesville
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 24.12.2025 · NCT06009276Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.